Literature DB >> 31419403

Extremes of Age Decrease Survival in Adults After Lung Transplant.

Carli J Lehr1, Eugene H Blackstone2, Kenneth R McCurry2, Lucy Thuita2, Wayne M Tsuang1, Maryam Valapour3.   

Abstract

BACKGROUND: Age has been implicated as a factor in the plateau of long-term survival after lung transplant.
METHODS: We used data from the Scientific Registry of Transplant Recipients to identify all recipients of lung transplant aged ≥18 years of age between January 1, 2006, and February 19, 2015. A total of 14,253 patients were included in the analysis. Survival was estimated using a nonproportional hazard model and random-survival forest methodology was used to examine risk factors for death. Final selection of model variables was performed using bootstrap aggregation. Age was analyzed as both a continuous and categorical variable (age <30, 30-55, and >55 years). Risk factors for death were obtained for the entire cohort and additional age-specific risk factors were identified for each age category.
RESULTS: The median age at transplant was 59 years. There were 1,098 (7.7%) recipients <30 years, 4,201 (29.5%) 30 to 55 years, and 8,954 (62.8%) >55 years of age. Age was the most significant risk factor for death at all time-points following transplant and its impact becomes more prominent as time from transplant increases. Risk factors for death for all patients included extremes of age, higher creatinine, single lung transplant, hospitalization before transplant, and increased bilirubin. Risk factors for death differed by age with social determinants of health disproportionately affecting survival for those in the youngest age category.
CONCLUSIONS: The youngest and oldest adult recipients experienced the lowest posttransplant survival through divergent pathways that may present opportunities for intervention to improve survival after lung transplant.
Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  lung transplant; lung transplant outcomes; organ allocation; random survival forest

Year:  2019        PMID: 31419403     DOI: 10.1016/j.chest.2019.06.042

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

Review 2.  Disparities in heart and lung transplantation.

Authors:  Wayne Tsuang; Rola Khedraki; Eileen Hsich
Journal:  Curr Opin Organ Transplant       Date:  2021-10-01       Impact factor: 2.269

3.  Deconstructing Silos of Knowledge Around Lung Transplantation to Support Patients: A Patient-specific Search of Scientific Registry of Transplant Recipients Data.

Authors:  Ajay K Israni; David Schladt; Marilyn J Bruin; Sauman Chu; Jon J Snyder; Marshall Hertz; Maryam Valapour; Bertram Kasiske; Warren T McKinney; Cory R Schaffhausen
Journal:  Transplantation       Date:  2022-02-11       Impact factor: 5.385

4.  Indications for Lung Transplantation and Patient Selection.

Authors:  Joohyung Son; Changwon Shin
Journal:  J Chest Surg       Date:  2022-08-05

5.  Risk factors for mortality in lung transplant recipients aged ≥65 years: A retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients.

Authors:  Christopher L Mosher; Jeremy M Weber; Courtney W Frankel; Megan L Neely; Scott M Palmer
Journal:  J Heart Lung Transplant       Date:  2020-10-31       Impact factor: 10.247

6.  Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibody detection in lung transplant recipients: A single-center experience.

Authors:  Tathagat Narula; Samir Khouzam; Francisco Alvarez; David Erasmus; Zhuo Li; Yousif Abdelmoneim; Mohamed Elrefaei
Journal:  Immun Inflamm Dis       Date:  2021-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.